Teratogenic potential of antiepileptic drugs in the zebrafish model. 2013

Sung Hak Lee, and Jung Won Kang, and Tao Lin, and Jae Eun Lee, and Dong Il Jin
Department of Animal Science & Biotechnology, Chungnam National University, Daejeon 305-764, Republic of Korea.

The zebrafish model is an attractive candidate for screening of developmental toxicity during early drug development. Antiepileptic drugs (AEDs) arouse concern for the risk of teratogenicity, but the data are limited. In this study, we evaluated the teratogenic potential of seven AEDs (carbamazepine (CBZ), ethosuximide (ETX), valproic acid (VPN), lamotrigine (LMT), lacosamide (LCM), levetiracetam (LVT), and topiramate (TPM)) in the zebrafish model. Zebrafish embryos were exposed to AEDs from initiation of gastrula (5.25 hours post-fertilization (hpf)) to termination of hatching (72 hpf) which mimic the mammalian teratogenic experimental design. The lethality and teratogenic index (TI) of AEDs were determined and the TI values of each drug were compared with the US FDA human pregnancy categories. Zebrafish model was useful screening model for teratogenic potential of antiepilepsy drugs and was in concordance with in vivo mammalian data and human clinical data.

UI MeSH Term Description Entries
D010889 Piracetam A compound suggested to be both a nootropic and a neuroprotective agent. 2-Pyrrolidone-N-Acetamide,Avigilen,Axonyl,Cerebroforte,Cerepar N,Ciclofalina,Cuxabrain,Dinagen,Gabacet,Geram,Memo-Puren,Nootrop,Nootropil,Nootropyl,Normabraïn,Piracebral,Piracetam AbZ,Piracetam-RPh,Piracetrop,Pirazetam,Pyracetam,Pyramem,Sinapsan,UCB-6215,Memo Puren,Piracetam RPh,UCB 6215,UCB6215
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D005013 Ethosuximide An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures. Ethosuccimid,Emeside,Ethylmethylsuccimide,Ethymal,Etosuximida Faes,Petnidan,Pyknolepsinum,Suksilep,Suxilep,Zarontin,Faes, Etosuximida
D005260 Female Females
D005632 Fructose A monosaccharide in sweet fruits and honey that is soluble in water, alcohol, or ether. It is used as a preservative and an intravenous infusion in parenteral feeding. Levulose,Apir Levulosa,Fleboplast Levulosa,Levulosa,Levulosa Baxter,Levulosa Braun,Levulosa Grifols,Levulosa Ibys,Levulosa Ife,Levulosa Mein,Levulosado Bieffe Medit,Levulosado Braun,Levulosado Vitulia,Plast Apyr Levulosa Mein,Levulosa, Apir,Levulosa, Fleboplast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077213 Lamotrigine A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER. 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine,3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine,BW-430C,Crisomet,Labileno,Lamictal,Lamiktal,BW 430C,BW430C
D000077236 Topiramate A sulfamate-substituted fructose analog that was originally identified as a hypoglycemic agent. It is used for the treatment of EPILEPSY and MIGRAINE DISORDERS, and may also promote weight loss. 2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate,Epitomax,McN 4853,McN-4853,Topamax,USL255,McN4853

Related Publications

Sung Hak Lee, and Jung Won Kang, and Tao Lin, and Jae Eun Lee, and Dong Il Jin
March 1975, Epilepsia,
Sung Hak Lee, and Jung Won Kang, and Tao Lin, and Jae Eun Lee, and Dong Il Jin
March 2008, Seizure,
Sung Hak Lee, and Jung Won Kang, and Tao Lin, and Jae Eun Lee, and Dong Il Jin
June 2010, Expert review of neurotherapeutics,
Sung Hak Lee, and Jung Won Kang, and Tao Lin, and Jae Eun Lee, and Dong Il Jin
September 2012, The Lancet. Neurology,
Sung Hak Lee, and Jung Won Kang, and Tao Lin, and Jae Eun Lee, and Dong Il Jin
November 1981, British medical journal (Clinical research ed.),
Sung Hak Lee, and Jung Won Kang, and Tao Lin, and Jae Eun Lee, and Dong Il Jin
August 1981, British medical journal (Clinical research ed.),
Sung Hak Lee, and Jung Won Kang, and Tao Lin, and Jae Eun Lee, and Dong Il Jin
June 2019, Pharmacological reports : PR,
Sung Hak Lee, and Jung Won Kang, and Tao Lin, and Jae Eun Lee, and Dong Il Jin
March 2014, Indian journal of pharmaceutical sciences,
Sung Hak Lee, and Jung Won Kang, and Tao Lin, and Jae Eun Lee, and Dong Il Jin
February 2016, Journal of visualized experiments : JoVE,
Sung Hak Lee, and Jung Won Kang, and Tao Lin, and Jae Eun Lee, and Dong Il Jin
October 2016, Experimental and therapeutic medicine,
Copied contents to your clipboard!